Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Implant

NCT ID: NCT01993862

Last Updated: 2019-02-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

266 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-03-17

Study Completion Date

2016-08-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether it is safe to send patients home from the hospital on the same day following an implantable cardioverter defibrillator (ICD) implant.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

SDD for ICD is a prospective, randomized, multi-center study designed to show that SDD is safe in a defined patient population receiving an ICD implant and that this approach can be more cost effective for the hospital than the current NDD approach. Safety is to be demonstrated by showing that postoperative complications do not occur at a higher rate in the SDD group of patients when compared to the NDD group. Cost effectiveness is to be demonstrated by comparing health care utilization between the SDD and NDD groups for the first week post implantation. Patients who were implanted with a St. Jude Medical single or dual chamber ICD for primary prevention and who met all inclusion and exclusion criteria may be enrolled in the study. Patients areconsidered enrolled at the point of randomization.

Randomization is assigned in a 1:1 ratio between the NDD group and the SDD group. Patients will undergo study evaluations after implant, pre-discharge, 1-week and 6 months post implant.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Next Day Discharge

The patient will have a 23 hour standard of care observational stay in the hospital after an implantable cardioverter defibrillator implant procedure.

Group Type NO_INTERVENTION

No interventions assigned to this group

Same Day Discharge

The patient will be discharged from the hospital the same evening after an implantable cardioverter defibrillator implant procedure. Follow up after surgery will be done via remote device follow up (1) on the day of discharge and (2) 24 hours after surgery.

Group Type ACTIVE_COMPARATOR

Same Day Discharge

Intervention Type OTHER

Patients will send device data remotely to their physician on the day of discharge from the hospital and again 24 hours after discharge from the hospital.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Same Day Discharge

Patients will send device data remotely to their physician on the day of discharge from the hospital and again 24 hours after discharge from the hospital.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient has a St Jude Medical device that is compatible with Merlin.net (remote monitoring)
* Patient is receiving an implantable cardioverter defibrillator for primary prevention
* Patient lives within 50 miles of an emergency room or 24 hour urgent care
* Patient is able to sign informed consent

Exclusion Criteria

* Patient experiences a complication during or 4 hours after implantable cardioverter defibrillator procedure
* Physician elects to keep the patient in over night due to a change in medical condition or a pre-existing condition that requires administration of continuous blood thinners
* Physician is unable to program the implantable cardioverter defibrillator to collect all required information remotely from device
* Patient is pregnant
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abbott Medical Devices

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Indrajit Choudhuri, MD

Role: PRINCIPAL_INVESTIGATOR

University of Wisconsin, Madison

Ranjit Suri, MD

Role: PRINCIPAL_INVESTIGATOR

Heart Rhythm Associates of New York, NY

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Heart Center Research

Huntsville, Alabama, United States

Site Status

Cardiology Associates of Mobile

Mobile, Alabama, United States

Site Status

John C Lincoln North Mountain Hospital

Phoenix, Arizona, United States

Site Status

Chula Vista Cardiac Center

Chula Vista, California, United States

Site Status

Cardiovascular Consultants Heart Center

Fresno, California, United States

Site Status

Stanislaus Cardiology Group

Modesto, California, United States

Site Status

Sutter Medical Center of Santa Rosa

Santa Rosa, California, United States

Site Status

Exempla Rocky Mountain Cardiovascular Associates

Broomfield, Colorado, United States

Site Status

South Denver Cardiology Associates PC

Littleton, Colorado, United States

Site Status

Lakeland Regional Medical Center

Lakeland, Florida, United States

Site Status

Watson Clinic Center

Lakeland, Florida, United States

Site Status

Florida Cardiovascular Specialists

Leesburg, Florida, United States

Site Status

Naples Heart Rhythm Specialists, PA

Naples, Florida, United States

Site Status

Loyola University Medical Center

Maywood, Illinois, United States

Site Status

Chicago Cardiology Institute

Schaumburg, Illinois, United States

Site Status

Ochsner Medical Center

New Orleans, Louisiana, United States

Site Status

Delmarva Heart

Salisbury, Maryland, United States

Site Status

Thoracic Cardiovascular Healthcare Foundation

Lansing, Michigan, United States

Site Status

Great Lakes Heart and Cascular Institute PC

Saint Joseph, Michigan, United States

Site Status

Jackson Heart Clinic

Jackson, Mississippi, United States

Site Status

Missouri Baptist Medical Center

St Louis, Missouri, United States

Site Status

St. Louis Heart and Vascular PC

St Louis, Missouri, United States

Site Status

The New York Hospital Queens

Flushing, New York, United States

Site Status

St. Luke's Hospital - Roosevelt

New York, New York, United States

Site Status

Cary Cardiology, PA

Cary, North Carolina, United States

Site Status

Cardiology Consultants

Johnson City, Tennessee, United States

Site Status

Arrhythmia Associates of South Texas

San Antonio, Texas, United States

Site Status

Aurora Medical Group

Milwaukee, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

40009529/B

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Trop-Shock DFT-testing Versus None
NCT01230086 COMPLETED PHASE4
Novel ICD Arrhythmia Detection Algorithm
NCT04981496 ACTIVE_NOT_RECRUITING